This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Under $10 Set to Soar

Endocyte

Another under-$10 name in the biotechnology and drugs complex that looks ready to trigger a major breakout trade is Endocyte (ECYT), which is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is off to a red-hot start in 2012, with shares up over 110%.

If you take a look at the chart for Endocyte, you'll notice that this stock has been uptrending very strong since mid-May, with shares soaring from around $6.07 a share to a recent high of $8.55 a share. During that solid uptrend, shares of Endocyte have been making mostly higher lows and higher highs, which is bullish technical price action. Over the last few weeks, shares of Endocyte have been moving sideways between $7.75 a share and $8.55 a share. That sideways action is now setting up ECYT for a near-term breakout trade if the stock can manage to clear the upper-end of its recent range.

>>4 Drug Stocks Facing FDA Approval Decision

Market players should now look for long-biased trades in ECYT if it can manage to trigger a break out above some near-term overhead resistance at $8.55 to $8.57 a share with high-volume. Look for volume off a sustained move or close above those levels that hits near or above its three-month average action of 819,995 shares. If we get that move soon, then this stock could explode to the upside and trend back towards its next major overhead resistance levels at $11.11 to $11.63 a share, or possibly even $12.65 to $13.50 a share.

If you like the setup here for ECYT, then one could buy this stock off any weakness and simply use a stop just below $7.86 to $7.75 a share, or even right below its 50-day moving average of $7.18 a share. If you get long off weakness, then I would add aggressively once $8.55 to $8.57 is taken out with volume. You could also just buy off strength once $8.55 to $8.57 are cleared with volume, and simply use a stop a few percentage points below that level ,or just below $7.86 a share.

The short-sellers are circling around this stock, since the current short interest as a percentage of the float for ECYT is very high at 13.4%. The bears have also been increasing their bets from the last reporting period by 25.9%, or by about 657,000 shares. The bears will not be happy to see ECYT trigger that breakout soon, so look for them to cover and push it sharply higher if it triggers soon.

5 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,193.88 -85.86 -0.50%
S&P 500 1,994.24 -16.16 -0.80%
NASDAQ 4,518.8470 -60.9420 -1.33%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs